Ensartinib
10mM in DMSO
- Product Code: 181285
CAS:
1365267-27-1
| Molecular Weight: | 547.41 g./mol | Molecular Formula: | C₂₅H₂₅Cl₂FN₆O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used as a targeted therapy in non-small cell lung cancer (NSCLC) with ALK gene rearrangements. It inhibits anaplastic lymphoma kinase (ALK) and ROS1 tyrosine kinases, blocking signaling pathways that drive tumor growth. Shows activity against brain metastases due to its ability to cross the blood-brain barrier. Employed in patients who are resistant to or intolerant of first-generation ALK inhibitors. Currently evaluated in clinical trials for efficacy and safety in advanced NSCLC.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿1,850.00 |
+
-
|
Ensartinib
Used as a targeted therapy in non-small cell lung cancer (NSCLC) with ALK gene rearrangements. It inhibits anaplastic lymphoma kinase (ALK) and ROS1 tyrosine kinases, blocking signaling pathways that drive tumor growth. Shows activity against brain metastases due to its ability to cross the blood-brain barrier. Employed in patients who are resistant to or intolerant of first-generation ALK inhibitors. Currently evaluated in clinical trials for efficacy and safety in advanced NSCLC.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :